Castle Biosciences, Inc. Common Stock CSTL
$35.75
-2.80%
at last close
Financials (TTM)
- Revenue
- $357.28 million
- Net Income
- $-19,415,000
- Net Margin
- -5.43%
- Return on Equity
- -4.13%
- Debt-to-Equity
- 0.02
- P/E Ratio
- —
- Price / Book
- 2.39
- Price / Sales
- 3.14
Over the trailing twelve months, Castle Biosciences, Inc. Common Stock generated revenue of $357.28 million and net income of $-19,415,000, a net margin of -5.43%.
At the last closing price of $35.75, CSTL trades at 3.14 times sales, with a market capitalization of $1.12 billion.
Key Stats
- Last Close
- $35.75
- Market Cap
- $1.12 billion
- 52-Week Range
- $17.72 – $44.28
- Average Volume
- 333K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.